Your browser doesn't support javascript.
loading
Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling.
Baraka, Sarah A; Tolba, Mai F; Elsherbini, Doaa A; El-Naga, Reem N; Awad, Azza S; El-Demerdash, Ebtehal.
  • Baraka SA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Egypt.
  • Tolba MF; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain-shams University, Cairo, Egypt.
  • Elsherbini DA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain-shams University, Cairo, Egypt.
  • El-Naga RN; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain-shams University, Cairo, Egypt.
  • Awad AS; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Egypt.
  • El-Demerdash E; Pharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
Clin Exp Pharmacol Physiol ; 48(10): 1358-1370, 2021 10.
Article en En | MEDLINE | ID: mdl-34081810

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas / Factor 2 Relacionado con NF-E2 / Rosuvastatina Cálcica / Carvedilol / Hemo Oxigenasa (Desciclizante) / Isoproterenol / Infarto del Miocardio Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas / Factor 2 Relacionado con NF-E2 / Rosuvastatina Cálcica / Carvedilol / Hemo Oxigenasa (Desciclizante) / Isoproterenol / Infarto del Miocardio Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article